Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mohammed Orloff

Concepts (236)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genetic Predisposition to Disease
11
2024
508
1.090
Why?
Germ-Line Mutation
9
2013
61
1.070
Why?
Hamartoma Syndrome, Multiple
8
2012
15
1.060
Why?
PTEN Phosphohydrolase
13
2015
53
1.040
Why?
Barrett Esophagus
2
2019
30
1.010
Why?
Esophageal Neoplasms
2
2019
104
0.930
Why?
Adenocarcinoma
3
2019
402
0.830
Why?
Haplotypes
3
2020
83
0.770
Why?
Homozygote
3
2019
57
0.660
Why?
Polymorphism, Single Nucleotide
9
2021
483
0.660
Why?
Carcinoma, Non-Small-Cell Lung
1
2020
154
0.630
Why?
Proto-Oncogene Proteins c-akt
4
2012
155
0.590
Why?
Databases, Factual
1
2020
659
0.560
Why?
Alleles
6
2021
252
0.460
Why?
Lung Neoplasms
3
2020
601
0.450
Why?
Phosphatidylinositol 3-Kinases
2
2012
139
0.420
Why?
Genotype
6
2021
539
0.400
Why?
Scavenger Receptors, Class A
1
2011
39
0.370
Why?
Extracellular Matrix Proteins
1
2011
69
0.370
Why?
Genetic Variation
3
2021
215
0.300
Why?
Transcription Factors
1
2011
565
0.290
Why?
Breast Neoplasms
7
2017
1186
0.290
Why?
Humans
37
2024
49877
0.290
Why?
Thyroid Neoplasms
4
2012
112
0.280
Why?
Heart Defects, Congenital
2
2024
584
0.280
Why?
Case-Control Studies
4
2024
1129
0.270
Why?
Genes, Wilms Tumor
1
2005
1
0.250
Why?
Population
1
2005
8
0.250
Why?
Gene Frequency
3
2020
96
0.250
Why?
Glomerulosclerosis, Focal Segmental
1
2005
13
0.240
Why?
Genome
2
2019
66
0.240
Why?
Lamin Type A
1
2024
6
0.230
Why?
Capacity Building
1
2024
18
0.220
Why?
DNA Methylation
3
2024
544
0.220
Why?
Adult
16
2024
13344
0.220
Why?
Middle Aged
16
2021
12289
0.220
Why?
Linkage Disequilibrium
2
2020
37
0.210
Why?
Female
21
2024
26555
0.210
Why?
Smoke-Free Policy
1
2022
8
0.210
Why?
Tobacco Smoke Pollution
1
2022
47
0.200
Why?
Inheritance Patterns
1
2021
22
0.190
Why?
Phenotype
7
2021
728
0.180
Why?
Models, Genetic
5
2013
174
0.180
Why?
Risk Factors
5
2019
3608
0.180
Why?
Male
15
2024
25427
0.180
Why?
Succinate Dehydrogenase
2
2011
22
0.170
Why?
Stilbenes
2
2010
54
0.170
Why?
Aged
11
2020
9450
0.170
Why?
Fires
1
2020
13
0.170
Why?
Agriculture
1
2020
18
0.170
Why?
Tobacco Products
1
2021
125
0.170
Why?
Social Media
1
2021
98
0.170
Why?
Aged, 80 and over
5
2020
3137
0.160
Why?
Cluster Analysis
4
2013
233
0.160
Why?
Exome
1
2019
46
0.160
Why?
Genomics
1
2020
284
0.150
Why?
Cell Proliferation
3
2010
986
0.150
Why?
Pulmonary Disease, Chronic Obstructive
1
2020
130
0.150
Why?
Prostatic Neoplasms
2
2012
391
0.140
Why?
Gene Expression Regulation, Neoplastic
3
2010
824
0.140
Why?
Prognosis
2
2020
1957
0.140
Why?
Endometrial Neoplasms
2
2015
137
0.130
Why?
Leprosy
1
2016
6
0.130
Why?
Asthma
1
2020
282
0.130
Why?
Hypertension
1
2021
532
0.130
Why?
Emergency Service, Hospital
1
2020
482
0.130
Why?
Microsatellite Repeats
2
2012
37
0.120
Why?
Regression Analysis
2
2017
385
0.120
Why?
Aromatase
1
2015
8
0.120
Why?
Tuberculosis
1
2016
148
0.120
Why?
Arkansas
4
2024
1987
0.120
Why?
Genetic Linkage
2
2011
26
0.110
Why?
Young Adult
7
2021
4027
0.110
Why?
Adolescent
8
2021
6402
0.110
Why?
Sirolimus
2
2010
62
0.110
Why?
Genome-Wide Association Study
2
2012
163
0.110
Why?
Bone Morphogenetic Protein Receptors, Type I
1
2013
1
0.110
Why?
Smad4 Protein
1
2013
5
0.110
Why?
Genetic Testing
2
2010
119
0.110
Why?
Cohort Studies
3
2012
1406
0.110
Why?
Class I Phosphatidylinositol 3-Kinases
1
2012
17
0.110
Why?
Colonic Polyps
1
2013
36
0.100
Why?
Receptors, Cell Surface
1
2013
120
0.100
Why?
Mitochondrial Diseases
1
2012
42
0.100
Why?
Codon, Nonsense
1
2012
26
0.100
Why?
Flavin-Adenine Dinucleotide
1
2011
4
0.100
Why?
Antigens, CD
1
2013
215
0.100
Why?
NAD
1
2011
42
0.100
Why?
Genes, p53
1
2011
51
0.100
Why?
DNA, Neoplasm
1
2012
145
0.100
Why?
Siblings
1
2011
33
0.090
Why?
Gene Expression Profiling
3
2012
1028
0.090
Why?
Mutation, Missense
1
2012
103
0.090
Why?
Taxoids
1
2011
37
0.090
Why?
Adenoma
1
2012
111
0.090
Why?
Risk
1
2012
314
0.090
Why?
Software
1
2013
273
0.090
Why?
Intestinal Polyps
1
2010
7
0.090
Why?
Colorectal Neoplasms
2
2012
253
0.090
Why?
Receptors, Androgen
1
2010
46
0.090
Why?
Cephalometry
1
2010
19
0.090
Why?
Tumor Microenvironment
1
2012
221
0.090
Why?
Head
1
2010
70
0.080
Why?
Gene Dosage
1
2009
78
0.080
Why?
Carcinoma, Transitional Cell
1
2010
52
0.080
Why?
Intracellular Signaling Peptides and Proteins
1
2010
139
0.080
Why?
Patient Selection
1
2010
254
0.080
Why?
Cell Communication
1
2009
69
0.080
Why?
Drug Resistance, Neoplasm
1
2011
314
0.080
Why?
Age Factors
1
2012
1090
0.080
Why?
Urinary Bladder Neoplasms
1
2010
158
0.080
Why?
Immunohistochemistry
1
2011
972
0.080
Why?
Smoking
1
2012
506
0.080
Why?
Prevalence
2
2021
955
0.070
Why?
Prospective Studies
4
2017
2342
0.070
Why?
Chromosome Mapping
2
2021
158
0.070
Why?
Mass Screening
1
2010
346
0.070
Why?
Rural Population
2
2022
550
0.070
Why?
Cell Line, Tumor
4
2011
1388
0.070
Why?
Physical Chromosome Mapping
1
2005
7
0.070
Why?
Multiple Myeloma
1
2020
2915
0.070
Why?
Antineoplastic Agents
2
2011
1175
0.060
Why?
Frasier Syndrome
1
2005
1
0.060
Why?
Denys-Drash Syndrome
1
2005
3
0.060
Why?
Exons
1
2005
96
0.060
Why?
Child
5
2020
6826
0.060
Why?
CpG Islands
1
2024
106
0.060
Why?
Models, Theoretical
1
2005
172
0.060
Why?
Gene Expression Regulation
1
2008
964
0.050
Why?
Mutation
2
2010
1291
0.050
Why?
Biopsy
1
2005
591
0.050
Why?
Polyproteins
1
2022
2
0.050
Why?
Child, Preschool
3
2020
3863
0.050
Why?
Risk Assessment
2
2021
1253
0.050
Why?
Phosphoproteins
1
2022
111
0.050
Why?
RNA, Viral
1
2022
124
0.050
Why?
Cardiomyopathy, Hypertrophic, Familial
1
2021
5
0.050
Why?
United States Food and Drug Administration
1
2021
91
0.050
Why?
Membrane Glycoproteins
1
2022
244
0.050
Why?
Azacitidine
1
2020
34
0.050
Why?
Nutrition Surveys
1
2021
103
0.050
Why?
Loss of Heterozygosity
2
2012
77
0.050
Why?
United States
2
2021
4873
0.040
Why?
Stromal Cells
2
2012
72
0.040
Why?
Nicotine
1
2021
182
0.040
Why?
TOR Serine-Threonine Kinases
2
2010
76
0.040
Why?
Self Report
1
2021
202
0.040
Why?
Pedigree
2
2010
125
0.040
Why?
Seasons
1
2020
80
0.040
Why?
Neoplasms
1
2009
1233
0.040
Why?
Signal Transduction
3
2010
1608
0.040
Why?
Air Pollution
1
2020
45
0.040
Why?
Odds Ratio
1
2021
548
0.040
Why?
Phosphorylation
2
2010
526
0.040
Why?
Gene Expression
2
2012
612
0.040
Why?
Sensitivity and Specificity
2
2012
858
0.040
Why?
Predictive Value of Tests
2
2012
907
0.040
Why?
Treatment Outcome
2
2020
5174
0.040
Why?
Dexamethasone
1
2020
424
0.040
Why?
Infant
2
2020
3564
0.040
Why?
Angiopoietin-2
1
2017
15
0.040
Why?
Dose-Response Relationship, Drug
2
2010
1354
0.040
Why?
Angiopoietin-1
1
2017
16
0.040
Why?
Receptor, TIE-2
1
2017
16
0.040
Why?
Fibroblast Growth Factor 2
1
2017
35
0.030
Why?
Clinical Trials, Phase II as Topic
1
2017
46
0.030
Why?
Matrix Metalloproteinase 9
1
2017
86
0.030
Why?
Vascular Endothelial Growth Factor A
1
2017
183
0.030
Why?
Cross-Sectional Studies
1
2021
1573
0.030
Why?
Neovascularization, Pathologic
1
2017
153
0.030
Why?
Neoadjuvant Therapy
1
2017
118
0.030
Why?
HapMap Project
1
2015
3
0.030
Why?
Introns
1
2015
50
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
994
0.030
Why?
Pilot Projects
1
2016
702
0.030
Why?
Peutz-Jeghers Syndrome
1
2013
2
0.030
Why?
Databases, Genetic
1
2013
87
0.030
Why?
Genome, Human
1
2013
110
0.030
Why?
Validation Studies as Topic
1
2012
10
0.020
Why?
Penetrance
1
2012
6
0.020
Why?
Neoplasm Grading
1
2012
123
0.020
Why?
Genetic Association Studies
1
2012
115
0.020
Why?
Vincristine
1
2011
84
0.020
Why?
Anthracyclines
1
2011
29
0.020
Why?
Inhibitory Concentration 50
1
2010
71
0.020
Why?
Paclitaxel
1
2011
83
0.020
Why?
Formazans
1
2010
4
0.020
Why?
Tetrazolium Salts
1
2010
15
0.020
Why?
Immunoblotting
1
2010
116
0.020
Why?
Androgen Antagonists
1
2010
11
0.020
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
81
0.020
Why?
Drug Synergism
1
2010
152
0.020
Why?
HEK293 Cells
1
2011
216
0.020
Why?
Michigan
1
2010
17
0.020
Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2010
17
0.020
Why?
Mitogen-Activated Protein Kinases
1
2010
154
0.020
Why?
Point Mutation
1
2010
65
0.020
Why?
Epithelial Cells
1
2012
209
0.020
Why?
Neoplasm Transplantation
1
2010
84
0.020
Why?
Kidney Neoplasms
1
2012
172
0.020
Why?
Androgens
1
2010
67
0.020
Why?
Heredity
1
2009
2
0.020
Why?
Transplantation, Heterologous
1
2010
75
0.020
Why?
BRCA2 Protein
1
2009
16
0.020
Why?
Adenosine Triphosphate
1
2011
231
0.020
Why?
Endoscopy, Gastrointestinal
1
2010
76
0.020
Why?
BRCA1 Protein
1
2009
30
0.020
Why?
Comparative Genomic Hybridization
1
2009
46
0.020
Why?
Polymerase Chain Reaction
1
2011
456
0.020
Why?
Proteins
1
2012
347
0.020
Why?
Mice, Nude
1
2010
252
0.020
Why?
Chi-Square Distribution
1
2010
276
0.020
Why?
Algorithms
1
2013
613
0.020
Why?
Cell Cycle
1
2010
226
0.020
Why?
Protein Binding
1
2011
656
0.020
Why?
Gene Deletion
1
2010
267
0.020
Why?
Diagnosis, Differential
1
2012
1034
0.020
Why?
Cell Survival
1
2010
590
0.020
Why?
Incidence
1
2012
989
0.020
Why?
Neoplasm Invasiveness
1
2009
268
0.020
Why?
Neoplastic Stem Cells
1
2009
100
0.020
Why?
Promoter Regions, Genetic
1
2010
467
0.020
Why?
Membrane Proteins
1
2010
347
0.020
Why?
Cell Transformation, Neoplastic
1
2009
181
0.020
Why?
Neoplasm Staging
1
2011
749
0.020
Why?
Microscopy, Confocal
1
2008
83
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2009
409
0.020
Why?
Cell Differentiation
1
2011
649
0.020
Why?
Chromosome Aberrations
1
2009
295
0.020
Why?
Survival Rate
1
2010
905
0.020
Why?
Registries
1
2010
522
0.020
Why?
Chromosomes, Human
1
2005
41
0.020
Why?
Time Factors
1
2010
2890
0.010
Why?
Reproducibility of Results
1
2005
1183
0.010
Why?
Mice
1
2010
5657
0.010
Why?
Animals
1
2010
13098
0.010
Why?
Orloff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description